Mineralys Therapeutics Inc (MLYS): Congress and insider trades
Who in Congress and inside the company traded MLYS, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Mineralys Therapeutics Inc (MLYS) is a listed stock on NASDAQ.
- Insiders filed 2 open market buys worth $8.8M and 26 sells worth $13M, the latest filed 2026-09-24 (24 September 2026).
- Across 1 scored buy, Insiders averaged -12.1% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell.
- Data as of 2026-09-29 (29 September 2026).
Insider trades in MLYS
as of 2026-09-24| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 24 Sep 2026 | Slingsby Brian Taylor | sell | 104,320 | $28.81 | $3.0M | n/a |
| 25 Aug 2026 | Warren Eric | sell | 7,437 | $25.98 | $193K | n/a |
| 12 Aug 2026 | Rodman David Malcom | sell | 2,170 | $27.09 | $58.8K | n/a |
| 23 Jul 2026 | Warren Eric | sell | 7,438 | $26.87 | $200K | n/a |
| 20 Jul 2026 | Rodman David Malcom | sell | 416 | $26.53 | $11.0K | n/a |
| 15 Jul 2026 | Congleton Jon | sell | 10,700 | $27.24 | $291K | n/a |
| 15 Jul 2026 | Rodman David Malcom | sell | 6,349 | $26.61 | $169K | n/a |
| 15 Jul 2026 | Rodman David Malcom | sell | 14,058 | $27.58 | $388K | n/a |
| 10 Jul 2026 | Rodman David Malcom | sell | 2,171 | $30.30 | $65.8K | n/a |
| 30 Jun 2026 | Warren Eric | sell | 104,124 | $25.90 | $2.7M | n/a |
| 30 Jun 2026 | Congleton Jon | sell | 75,000 | $26.14 | $2.0M | n/a |
| 17 Jun 2026 | Rodman David Malcom | sell | 4,584 | $25.00 | $115K | n/a |
| 17 Jun 2026 | Karydas Daphne | sell | 3,000 | $25.00 | $75.0K | n/a |
| 17 Jun 2026 | Rodman David Malcom | sell | 9,890 | $23.81 | $235K | n/a |
| 12 Jun 2026 | Rodman David Malcom | sell | 2,170 | $25.00 | $54.3K | n/a |
| 12 Jun 2026 | Rodman David Malcom | sell | 6,349 | $23.93 | $152K | n/a |
| 19 May 2026 | Rodman David Malcom | sell | 417 | $27.55 | $11.5K | n/a |
| 21 Apr 2026 | Rodman David Malcom | sell | 416 | $31.33 | $13.0K | n/a |
| 15 Apr 2026 | Congleton Jon | sell | 15,730 | $26.83 | $422K | n/a |
| 15 Apr 2026 | Rodman David Malcom | sell | 6,348 | $27.66 | $176K | n/a |
| 15 Apr 2026 | Rodman David Malcom | sell | 14,058 | $26.54 | $373K | n/a |
| 13 Apr 2026 | Rodman David Malcom | sell | 2,170 | $27.38 | $59.4K | n/a |
| 2 Apr 2026 | Karydas Daphne | sell | 3,000 | $25.00 | $75.0K | n/a |
| 2 Apr 2026 | Congleton Jon | sell | 75,000 | $26.27 | $2.0M | n/a |
| 31 Mar 2026 | RA CAPITAL MANAGEMENT, L.P. | buy | 310,700 | $23.67 | $7.4M | -12.1% |
| 31 Mar 2026 | RA CAPITAL MANAGEMENT, L.P. | buy | 58,300 | $24.16 | $1.4M | -12.1% |
| 17 Mar 2026 | Rodman David Malcom | sell | 417 | $25.65 | $10.7K | n/a |
| 10 Mar 2026 | Rodman David Malcom | sell | 2,171 | $26.84 | $58.3K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought MLYS?
0 Congress buys by 0 members and 2 insider buys are on file. The tables on this page list every one.
Did buying MLYS after a disclosure beat the market?
Across 1 scored buy, Insiders averaged -12.1% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.